|
| |
| | Bristol-Myers Squibb Company and Medarex Form Global Development and Commercialization Collaboration for MDX-010 |
 | | Bristol-Myers Squibb will be responsible for all development outside of these territories. | | | Bristol- Myers Squibb and Medarex will share in the costs of developing MDX-010 and MDX-1379 in the United States and Europe based on a pre-agreed percentage allocation. | | | About Bristol-Myers Squibb Bristol-Myers Squibb is a global pharmaceutical and related health care products company whose mission is to extend and enhance human life. |
|
http://www.medarex.com/cgi-local/item.pl/20041108-641202
|
|
| |
| | Bristol-Myers Squibb Pharmaceutical Research Institute (PRI) |
| | The Medal was awarded to Bristol-Myers Squibb "for extending and enhancing human life through innovative pharmaceutical research and development, and for redefining the science of clinical study through groundbreaking and hugely complex clinical trials that are recognized models in the industry." | | | Bristol-Myers Squibb is concentrating on a number of other therapeutic areas, including immunology and inflammation (autoimmune/inflammatory disorders, rheumatoid arthritis, organ transplantation); pulmonary disease (asthma, chronic obstructive pulmonary disease, allergic rhinitis); and dermatology (inflammatory diseases, excessive hair growth, pigmentation, psoriasis, wound healing). | | | All of the company's resources and expertise in oncology research and development are marshaled toward the single goal of providing safer and more effective cancer medicines. |
|
http://www.biospace.com/company_profile.cfm?CompanyID=1319
|
|
| |
| | SWBIC - Bristol-Myers Squibb Company (more info) |
| | Bristol-Myers Squibb is a health and personal care company whose principal businesses are medicines, beauty care, nutritionals, and medical devices. |
|
http://darwin.nmsu.edu/cgi-bin/moreinfo.cgi?12262
|
|
| |
| | Mesothelioma News: ERBITUX--Cetuximab--Receives FDA Approval to Treat Irinotecan Refractory or Intolerant Metastatic Colorectal Cancer |
| | Bristol-Myers Squibb is dedicated to the discovery, development and exhaustive exploration of innovative cancer fighting therapies designed to extend and enhance the lives of patients living with cancer. | | | Bristol-Myers Squibb is a global pharmaceutical and related health care products company whose mission is to extend and enhance human life. | | | Although the company believes that the expectations reflected in such forward-looking statements are based upon reasonable assumptions, it can give no assurance that its expectations will be achieved. |
|
http://www.mesotheliomacenter.org/news/2004-02-12.php
|
|
| |
| | Company News On Call |
| | Bristol-Myers Squibb is a diversified, worldwide health and personal care company whose principal businesses are pharmaceuticals, consumer medicines, beauty care, nutritionals, and medical devices. | | | "Bristol-Myers Squibb is very pleased to work with Schering-Plough to help physicians treat the RTIs that affect people every day, especially this time of year," said Richard J. Lane, president, Bristol-Myers Squibb Worldwide Medicines Group. | | | Bristol-Myers Squibb is the largest manufacturer of penicillin in the world and the maker of some of the most prescribed antibiotics for adults and children, including TRIMOX(R) (amoxicillin), PRINCIPEN(R) (ampicillin), CEFZIL(R) (cefprozil) and DURICEF(R) (cefadroxil). |
|
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=105&STORY=/www/story/03-13-2000/0001162915
|
|
| |
| | CSRwire.com -- Corporate Social Responsibility Newswire |
| | As part of SECURE THE FUTURE, the company has created the Bristol-Myers Squibb HIV Research Institute to advance medical research by providing grants to fund research and training specifically designed to build health care infrastructure and achieve model programs for AIDS management. | | | The goal of the initiative is to create models of health care methods and systems where resources are extremely limited but needs are great and immediate. | | | Horizon treats the environment with concern and care, but that practice also extends to the cows themselves. |
|
http://www.csrwire.com/print.cgi?sfArticleId=69
|
|
| |
| | BRISTOL-MYERS SQUIBB COMPANY Jobs - Employment Opportunities at Monster.com |
| | Bristol-Myers Squibb is one of the great companies of the world, dedicated to extending and enhancing human life by providing the finest health and personal care products. | | | As a world leader in medicines, beauty and personal care products, nutritionals and medical devices, Bristol-Myers Squibb is dedicated to competitive superiority and to improving the lives of our millions of customers. | | | We pledge Bristol-Myers Squibb to the highest standard of moral and ethical behavior and to policies and procedures that fully embody the responsibility, integrity and decency required of free enterprise if it is to merit and maintain the confident of our society. |
|
http://company.monster.com/bms
|
|
| |
| | BioSpace News for |
| | Merck & Co.'s Zocor, Bristol-Myers Squibb Co.'s Pravachol and other cholesterol-reducing medicines may cut the risk of colon cancer by about half, according to a study in the May 26 issue of the New England Journal of Medicine. | | | Ernst & Young is optimistic that biotechnology as a whole will become profitable by 2009, pointing to some 365 drugs in the last stages of development compared to 290 in 2003. | | | People taking cholesterol drugs for five years had a 47 percent reduction in the risk of developing colon cancer than those who didn't take them, said Stephen Gruber, the study's lead author and an associate professor at the University of Michigan. |
|
http://www.biospace.com/news_company.cfm?CompanyID=1440&SR=71
|
|
| |
| | BRISTOL-MYERS SQUIBB COMPANY, New York, NY |
| | At Bristol-Myers Squibb (http://www.bms.com), our mission is to extend and enhance human life by providing the highest-quality pharmaceuticals and health care products. | | | Living--and living up to--the Bristol-Myers Squibb Pledge is crucial to our mission to extend and enhance human life, and is key to our future success. | | | What has enabled Bristol-Myers Squibb to achieve market leadership is an unwavering commitment to the values of excellence, reliability, growth, innovation, fairness and good citizenship. |
|
http://www.aeaweb.org/joe/0502d/html/joe059.html
|
|
| |
| | About Bristol-Myers Squibb Company |
| | In 1967, Mead Johnson merged with Bristol-Myers Company and triggered an expansion of the Company. | | | The company's mission began in 1887 in New York where two friends - William M. Bristol and John Ripley Myers - founded a company to sell medicines directly to doctors. | | | Mead Johnson was devoted to nutrition research and development and soon expanded to pediatrics and infant nutrition; E.R. Squibb and Son, Inc., was known for its meticulous standards of quality that revolutionized the development, manufacture and control of medical preparations. |
|
http://www.bms.com.ph/about.htm
|
|
| |
| | Bristol-Myers Squibb CIO on IT and Pharmaceutical Data |
| | Daniel E. Klingler, Ph.D., as CIO and senior vice president of Information and Knowledge Management for the Worldwide Medicines Group at Bristol-Myers Squibb, oversees all of the business processes that are part of the company's pharmaceutical business. | | | Klingler has responsibility for developing, delivering and supporting all of the applications that are used within the pharmaceutical area, including scientific R&D. CIO Insight spoke with him recently about the role of IT in the drug business—and how good project management rules can help speed results. | | | IT and Pharmaceutical Data: Finding Needles in Haystacks |
|
http://www.cioinsight.com/article2/0,1540,646432,00.asp
(1728 words)
|
|
| |
| | Iowa Priority - Prescription Savings Program |
| | Bristol Myers Squibb, the first manufacturer to participate in Iowa Priority, views the program as a meaningful interim solution for providing access to prescription medications. | | | Bristol-Myers Squibb Company and Merck & Co., Inc., make many medications commonly prescribed for conditions affecting the elderly in the Iowa Priority Prescription Savings Program, such as diabetes, high cholesterol, hypertension, arthritis, osteoporosis and glaucoma. | | | DES MOINES, Iowa - March 21, 2002 - Iowa Priority announced today that two of the nation's largest drug manufacturers are now offering Iowa seniors and others on Medicare significant discounts on medications that treat a wide range of medical conditions. |
|
http://www.iowapriority.org/newsrelease-newmeds.asp
(1728 words)
|
|
| |
| | Bristol-Myers Squibb Company (BMY) Won't Advertise New Drugs... |
| | Amid mounting criticism of advertising drugs directly to consumers, Bristol-Myers Squibb Co. pledged not to promote any of its new medicines directly to patients for at least a year. | | | Bristol-Myers Squibb Company (BMY) Won't Advertise New Drugs... | | | It is believed to be the first company to make such a promise but many drug makers have been changing the tenor of their advertising in response to rising complaints from doctors, patients and lawmakers about the amount and accuracy of the advertising. |
|
http://www.biospace.com/b2/news_story.cfm?StoryId=20358520
(1728 words)
|
|
| |
| | CW Resource |
| | Officials of Bristol-Myers Squibb, one of the world's largest pharmaceuticals companies, have met with Securities and Exchange regulators to discuss circumstances behind last year's sales to drug wholesalers. | | | There is no evidence at this time that Bristol behaved improperly or artificially inflated sales. | | | Several months ago, Bristol admitted that it was reducing shipments to wholesales in order to bring wholesaler inventories to a more appropriate level. |
|
http://myphlip.pearsoncmg.com/cw/mpviewce.cfm?vceid=3369&vbcid=3463
(1728 words)
|
|
| |
| | BioSpace News for |
| | SOMERSET, N.J., Sept. 16 /PRNewswire-FirstCall/ -- Ventiv Health, Inc., today announced that it has expanded its service relationship with Bristol-Myers Squibb Company and will be providing Medical Science Liaison assistance to Bristol-Myers Squibb for the anti-bacterial drug Tequin(R). | | | Ventiv Health, Inc. (VTIV) Provides Medical Science Liaisons To Bristol-Myers Squibb Company (BMY) | | | Orencia (abatacept;Bristol-Myers Squibb) is the first of a new class of drugs for RA. |
|
http://www.biospace.com/news_company.cfm?CompanyID=221104
(1728 words)
|
|
| |
| | ACVP > Career Center |
| | Bristol-Myers Squibb offers the opportunity to work with outstanding research and development scientists in a stimulating environment. | | | Bristol-Myers Squibb is a world leader oncology, infectious diseases, diabetes, immunology, neuroscience and cardiovascular research. | | | For the next generation of leaders in pharmaceutical research, Bristol-Myers Squibb is an excellent place to work. |
|
http://www.acvp.org/career/postings/062504b.php
(1728 words)
|
|
| |
| | EnglishLeague.com ESL Language Training : About us : Case studies : Bristol-Myers Squibb Company |
| | English League custom-developed a technical-writing syllabus specifically for Bristol-Meyers Squibb scientists and researchers. | | | The company approached us because some of its international researchers, mostly from China, needed help with their technical- writing skills. | | | We prioritized the technical-writing elements most relevant to our students, addressing each one of their weakest points in turn. |
|
http://www.englishleague.com/about/case_studies/bms.htm
(1728 words)
|
|
| |
| | Bristol-Myers Squibb "underweight," target price reduced newratings.com |
| | In a research note published yesterday, the analyst mentions that the sales of Bristol-Myers Squibb's major cholesterol-lowering drug, Pravachol, continues to be weak. | | | Bristol-Myers Squibb quote - chart - all headlines - analyst actions | | | NEW YORK, July 8 (newratings.com) - Analyst Tim Anderson of Prudential Financial maintains his "underweight" rating on Bristol-Myers Squibb (BMY.NYS), while reducing his estimates for the company. |
|
http://www.newratings.com/analyst_news/article_441854.html
(1728 words)
|
|
| |
| | Bristol-Myers Squibb - Wikipedia, the free encyclopedia |
| | The following is a list of key pharmaceutical products as found on the Bristol-Myers Squibb "At A Glance" information page, retrieved 2005-03-28. | | | Bristol-Myers Squibb manufactures prescription pharmaceuticals, Over-the-Counter drugs (see Excedrin) and health care products in several therapeutic areas. | | | Bristol-Myers Squibb NYSE: BMY, colloquially referred to as BMS, is a pharmaceutical corporation, formed by a 1989 merger between pharmaceutical companies Bristol-Myers Company and Squibb Corporation. |
|
http://en.wikipedia.org/wiki/Bristol-Myers_Squibb
(1728 words)
|
|
| |
| | Espicom - Bristol-Myers Squibb Company Intelligence Report |
| | Headquartered in New York, Bristol-Myers Squibb is involved in the research and development of treatments for conditions such as heart disease, high blood pressure, stroke, diabetes, cancer, HIV/AIDS, depression, schizophrenia and pain. | | | A cancer snapshot report is also available for Bristol-Myers Squibb. | | | This Company Intelligence Report was produced as part of Pharmaceutical Companies Analysis (PCA). |
|
http://www.espicom.com/web.nsf/structure/ph_bkscbms?OpenDocument
(1728 words)
|
|
| |
| | Bristol-Myers Squibb Company |
| | 08:00 ET Bristol-Myers Squibb to Pioneer Personalized Medicines for Cancer Patients | | | 09:17 ET Bristol-Myers Squibb & Karolinska Institute to Conduct Clinical Trials In Cancer Pharmacogenomics | | | 08:30 ET Bristol-Myers Squibb and Gilead Sciences Establish U.S. Joint Venture to Develop and Commercialize Fixed-Dose Combination of Three HIV Medicines |
|
http://www.prnewswire.com/comp/269329.html
(1728 words)
|
|
| |
| | FDA Expands Use Of Plavix (Clopidogrel Bisulfate) To Unstable Angina Or Heart Attack |
| | PARIS, FRANCE -- February 28, 2002 -- Sanofi-Synthelabo and Bristol-Myers Squibb Company announced that the U.S. Food and Drug Administration (FDA) has approved the antiplatelet medication Plavix® (clopidogrel bisulfate) for a new indication: acute coronary syndrome (ACS). | | | ACS is defined as unstable angina (chest pain) and non Q-wave myocardial infarction (mild heart attack). | | | To date, more than 11 million patients worldwide have been treated with Plavix. |
|
http://www.docguide.com/dg.nsf/PrintPrint/B396AB39A6F472FB85256B6E00639220
(1728 words)
|
|
| |
| | GeneFormatics and Bristol-Myers Squibb Enter Into Agreement to Identify Novel Therapeutic Targets Through Protein Function Prediction |
| | Bristol-Myers Squibb is a leader in pharmaceutical development and has an exceptional drug discovery program. | | | GeneFormatics' technology platform, which was initially developed at The Scripps Research Institute, combines the three most important areas of genomic research -- protein structure prediction, protein functional analysis and computer-aided molecular design. | | | This press release contains forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in the forward-looking statements. |
|
http://www.findwealth.com/geneformatics-and-bristol-myers-squibb-167168pr.html
(1728 words)
|
|
| |
| | PR Newswire : Bristol-Myers Squibb Company Announces Dividend. @ HighBeam Research |
| | Bristol-Myers Squibb is a diversified worldwide health and personal care company whose principal businesses are pharmaceuticals, consumer medicines, beauty care, nutritionals, and medical devices. | | | NEW YORK, March 2 /PRNewswire/ -- The Board of Directors of Bristol-Myers Squibb Company (NYSE: BMY) today declared a quarterly dividend of twenty-one and one-half cents ($0.215) per share on the Company's Common Stock, on a post-split basis. | | | A two-for-one stock split of the Common Stock was effected in the form of a stock dividend in February 1999. |
|
http://static.highbeam.com/p/prnewswire/march021999/bristolmyerssquibbcompanyannouncesdividend/index.html
(1728 words)
|
|
| |
| | MSN Money - BMY Key Developments: Investing |
| | Bristol-Myers Squibb Co. and ImClone Systems Inc. announced that ImClone Systems has submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for approval of ERBITUX (Cetuximab), an IgG1 monoclonal antibody in the treatment of Squamous Cell Carcinoma of the Head and Neck (SCCHN). | | | Bristol-Myers Squibb Co. announced that it has completed the sale of its U.S. and Canadian Consumer Medicines business to Novartis AG. | | | Bristol-Myers Squibb Co. announced that the U.S. Food and Drug Administration's (FDA) Arthritis Advisory Committee has recommended approval of ORENCIA (abatacept), the Company's investigational selective modulator of T-cell co-stimulation under development for the treatment of rheumatoid arthritis (RA). |
|
http://news.moneycentral.msn.com/ticker/sigdev.asp?Symbol=BMY
(1728 words)
|
|
| |
| | Bristol-Myers Squibb Company - Fact Sheet - Hoover's |
| | Bristol-Myers Squibb (BMS) may soon no longer be a headache sufferer's best friend. | | | There are 15 competitors for Bristol-Myers Squibb; see more. | | | The move makes sense: The bulk of the company's sales comes from prescription drugs. |
|
http://hoovers.com/bristol-myers-squibb/--ID__10232--/free-co-factsheet.xhtml
(1728 words)
|
|
| |
| | Bristol-Myers Squibb Company -- Encyclopædia Britannica |
| | Bristol is also the home of the New England Carousel Museum and the... | | | "New York-based global health and personal care company manufacturing products related to medicines, nutritionals, medical devices, and beauty care. | | | Pharmaceutical companies poured money into direct-to-consumer (DTC) promotions of prescription drugs in 1998, accelerating their efforts of 1997. |
|
http://www.britannica.com/eb/article-9016502?tocId=9016502
(1728 words)
|
|
| |
| | CNN.com - States sue Bristol-Myers Squibb - Dec. 12, 2001 |
| | NEW YORK (CNN/Money) -- More than two dozen states have sued Bristol-Myers Squibb for allegedly making inaccurate statements to federal regulators, preventing a lower-cost generic form of the company's anti-anxiety drug BuSpar from coming to market. | | | The lawsuit, filed by 28 states and Puerto Rico, claims that New York-based Bristol-Myers Squibb (BMY: down $3.55 to $50.20, Research, Estimates) violated antitrust, consumer protection and unfair competition laws, the Pennsylvania attorney general's office said in a statement. | | | During that time period, Pennsylvania spent $3.5 million on BuSpar prescriptions for state Medicaid and other benefit programs. |
|
http://robots.cnn.com/2001/BUSINESS/12/12/buspar
(1728 words)
|
|
|
